#United States #Philadelphia #Children's Hospital #Hematology #Stella Chou

New Leadership at Children’s Hospital of Philadelphia

The Children's Hospital of Philadelphia (CHOP) has made a significant announcement regarding its Division of Hematology. Dr. Stella T. Chou has been appointed as the new Chief, effective July 1, 2026, following her tenure as interim chief since August 2025. This transition cements Dr. Chou's role at the helm of one of the largest and most reputable pediatric hematology programs in the United States.

A Trailblazer in Pediatric Hematology

Dr. Chou is a highly respected physician scientist who has dedicated much of her career to advancing research in sickle cell disease, transfusion medicine, and the development of blood cells. Her groundbreaking work has transformed the understanding of how red blood cells respond to immune challenges in sickle cell disease, while also enhancing transfusion support strategies. With her NIH-funded laboratory, Dr. Chou has made key discoveries in developmental hematology and stem cell biology, including vital insights into GATA1's role in blood cell formation, hematopoiesis associated with Down syndrome, and innovative models of blood disorders using induced pluripotent stem cells.

Recently, Dr. Chou's research has ventured into creating personalized transfusion solutions and synthetic blood products, highlighting her commitment to leading-edge treatment advancements. "I am honored to lead our outstanding Division of Hematology," stated Dr. Chou, who also holds a professorship at the Perelman School of Medicine of the University of Pennsylvania and oversees the Division of Transfusion Medicine at CHOP.

A Vision for Patient-Centered Care

Dr. Chou's vision reflects a deep commitment to the children and families under her care. She anticipates engaging with CHOP's talented faculty and staff to elevate patient care standards, advance research initiatives, and enhance education within the division.

CHOP's hematology program is recognized as a Qualified Treatment Center, which means it provides comprehensive care for various non-malignant blood disorders affecting children, such as thalassemia, sickle cell disease, and hemophilia. The hospital is equipped with the latest treatment modalities, including FDA-approved gene therapies aimed at curing transfusion-dependent beta thalassemia and sickle cell disease.

Professional Achievements and Recognition

Dr. Chou's contributions to the field have not gone unnoticed. She has played a pivotal role within prestigious organizations such as the American Society of Hematology (ASH) and the Association for the Advancement of Blood and Biotherapies (AABB). Her leadership has fostered collaboration across various medical divisions and departments, making CHOP a beacon of excellence in hematology and transfusion medicine.

In addition to her leadership at CHOP, Dr. Chou has been recognized globally, having been invited to lecture worldwide and shape clinical guidelines on sickle cell disease and transfusion strategies. As a testament to her significant impact in the field, she was inducted into the AABB National Hall of Fame in 2018 and had the honor of serving as a Presidential Symposium Lecturer at ASH in 2020. This year, she is set to receive the prestigious William Dameshek Prize at the upcoming 2026 ASH Annual Meeting in New Orleans.

Educational Background

Dr. Chou earned her undergraduate degree from Duke University and completed her medical training at New York Medical College. Her professional journey has been primarily associated with CHOP and Penn Medicine, where she undertook her pediatric residency, hematology-oncology fellowship, and further specialization in transfusion medicine.

As a mentor and leader, Dr. Chou has actively participated in shaping future medical talents, notably through her role as Co-Director of the NIH-NHLBI-supported Pediatric Hematology T32 Research Training Program at CHOP.

About Children's Hospital of Philadelphia

Established in 1855, CHOP is the oldest pediatric hospital in the United States, dedicated to delivering exceptional healthcare while training the next generation of pediatric professionals and conducting groundbreaking research. The hospital has amassed one of the largest pediatric research programs in the country and maintains a vast network of care facilities across Pennsylvania, New Jersey, and Delaware. The institution also champions children's rights through its community service initiatives.

For further information about CHOP and its wide array of services, visit www.chop.edu.